荃信生物-B盘中异动股价大涨6.15%报13.800港元

市场透视11-06

2024年11月06日早盘09时34分，荃信生物-B（02509.hk）股票出现波动，股价急速拉升6.15%。截至发稿，该股报13.800港元/股，成交量0股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出0港元。最近的财报数据显示，该股实现营业收入4,921.66万港元，净利润-1.89亿港元，每股收益-0.87港元，毛利4,136.83万港元，市盈率-5.48倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2481952176?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-06 09:34","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2481952176","market":"hk","top_or_hot":-1,"title":"荃信生物-B盘中异动 股价大涨6.15%报13.800港元","media":"市场透视","content":"<div>\n<p>2024年11月06日早盘09时34分，荃信生物-B（02509.hk）股票出现波动，股价急速拉升6.15%。截至发稿，该股报13.800港元/股，成交量0股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出0港元。最近的财报数据显示，该股实现营业收入4,921.66万港元，净利润-1.89亿港元，每股收益-0.87港元，毛利4,136.83万港元，市盈率-5.48倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110609343998e40add&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>荃信生物-B盘中异动 股价大涨6.15%报13.800港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n荃信生物-B盘中异动 股价大涨6.15%报13.800港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-06 09:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110609343998e40add&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2024年11月06日早盘09时34分，荃信生物-B（02509.hk）股票出现波动，股价急速拉升6.15%。截至发稿，该股报13.800港元/股，成交量0股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出0港元。最近的财报数据显示，该股实现营业收入4,921.66万港元，净利润-1.89亿港元，每股收益-0.87港元，毛利4,136.83万港元，市盈率-5.48倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110609343998e40add&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110609343998e40add&s=b","article_id":"2481952176","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110609343998e40add&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2481952176","pubTimestamp":1730856877,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2024年11月06日早盘09时34分，荃信生物-B股票出现波动，股价急速拉升6.15%。截至发稿，该股报13.800港元/股，成交量0股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出0港元。荃信生物-B股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，荃信生物-B、亚盛医药-B、金斯瑞生物科技涨幅较大，振幅较大的相关个股有科济药业-B、歌礼制药-B、巨子生物，振幅分别为6.68%、5.56%、4.34%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","02509":"荃信生物-B"},"translate_title":"Quanxin Biotech-B's intraday stock price rose 6.15% to HK $13.800","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"2024年11月06日早盘09时34分，荃信生物-B（02509.hk）股票出现波动，股价急速拉升6.15%。截至发稿，该股报13.800港元/股，成交量0股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出0港元。最近的财报数据显示，该股实现营业收入4,921.66万港元，净利润-1.89亿港元，每股收益-0.87港元，毛利4,136.83万港元，市盈率-5.48倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。荃信生物-B股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，荃信生物-B、亚盛医药-B、金斯瑞生物科技涨幅较大，振幅较大的相关个股有科济药业-B、歌礼制药-B、巨子生物，振幅分别为6.68%、5.56%、4.34%。荃信生物-B公司简介：江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自体免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域,包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个,目标适应症包括干癣、异位性皮肤炎、类风湿性关节炎、发炎性肠道疾病、气喘等。该公司核心产品有QX002N和QX005N。消息层面，截至09时34分，《荃信生物首款商业化产品获批 合作方华东医药：对业绩有一定作用》资讯为影响荃信生物-B的重要信息。该信息摘要如下：荃信生物称，赛乐信是中国首个获批的乌司奴单抗注射液生物类似药，同时也是荃信生物首个商业化的产品。从商业化角度，赛乐信在中国大陆区域的商业化将由中美华东负责。华东医药表示，赛乐信的上市不会对当前财务状况和经营成果产生重大影响，对未来业绩提升有一定积极作用。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481952176"}

荃信生物-B盘中异动 股价大涨6.15%报13.800港元

精彩评论

荃信生物-B盘中异动股价大涨6.15%报13.800港元